Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?

Sasaki, M; Sato, Y; Nakanuma, Y

Sasaki, M; Sato, Y; Nakanuma, Y.

Affiliation

Sasaki M; Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Sato Y; Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Nakanuma Y; Division of Pathology, Fukui Saiseikai Hospital, Fukui, Japan.

Histopathology ; 80(5): 859-868, 2022 Apr.

Article in En | MEDLINE | ID: mdl-35076959

Subject(s)

Bile Duct Neoplasms/diagnosis; Biomarkers, Tumor/analysis; Carcinoma, Hepatocellular/diagnosis; Cholangiocarcinoma/diagnosis; Liver Neoplasms/diagnosis; Nestin/analysis; Adult; Aged; Bile Duct Neoplasms/genetics; Bile Duct Neoplasms/pathology; Biomarkers, Tumor/genetics; Carcinoma, Hepatocellular/genetics; Carcinoma, Hepatocellular/pathology; Cholangiocarcinoma/genetics; Cholangiocarcinoma/pathology; Female; Genes, p53/genetics; Humans; Immunohistochemistry; Liver Neoplasms/genetics; Liver Neoplasms/pathology; Male; Middle Aged; Mutation; Neoplasm Grading; Nestin/genetics

Key words

combined hepatocellular and cholangiocarcinoma; intrahepatic cholangiocarcinoma; nestin; p53; small duct type

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Bile Duct Neoplasms / Biomarkers, Tumor / Cholangiocarcinoma / Carcinoma, Hepatocellular / Nestin / Liver Neoplasms Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Histopathology Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google